-
公开(公告)号:US10894042B2
公开(公告)日:2021-01-19
申请号:US15525771
申请日:2015-11-10
申请人: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITÉ PARIS DIDEROT—PARIS 7
发明人: Alain Couvineau , Valérie Gratio , Pascal Nicole , Thierry Voisin
IPC分类号: A61K31/49 , A61K31/47 , A61K45/06 , A61K31/435 , A61K31/5513 , A61P35/00 , A61K31/472 , A61K31/551
摘要: The present invention relates to methods and pharmaceutical compositions for the treatment of cancer. More particularly, the present invention relates to a method of treating cancer in subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one OX1R antagonist.
-
2.
公开(公告)号:US10172921B2
公开(公告)日:2019-01-08
申请号:US15320827
申请日:2015-06-23
申请人: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITÉ PARIS DIDEROT—PARIS 7 , ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS
摘要: The present invention relates to methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases. The presents methods relates to a method of treating an inflammatory bowel disease in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one OX1R agonist.
-